ECTODOL Trademark

Trademark Overview

On Wednesday, May 30, 2018, a trademark application was filed for ECTODOL with the United States Patent and Trademark Office. The USPTO has given the ECTODOL trademark a serial number of 79241353. The federal status of this trademark filing is REGISTERED as of Tuesday, September 17, 2019. This trademark is owned by BRILL PHARMA, S.L.. The ECTODOL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for ophthalmological and otorhinolaryngological use; pharmaceutical products for treating respiratory diseases; dermatological pharmaceutical products, all the foregoing excluding pharmaceuticals for the liver, thyroid and hyperproliferative diseases
ectodol

General Information

Serial Number79241353
Word MarkECTODOL
Filing DateWednesday, May 30, 2018
Status700 - REGISTERED
Status DateTuesday, September 17, 2019
Registration Number5859380
Registration DateTuesday, September 17, 2019
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 2, 2019

Trademark Statements

Goods and ServicesPharmaceutical products for ophthalmological and otorhinolaryngological use; pharmaceutical products for treating respiratory diseases; dermatological pharmaceutical products, all the foregoing excluding pharmaceuticals for the liver, thyroid and hyperproliferative diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 28, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBRILL PHARMA, S.L.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressES
Party NameBRILL PHARMA, S.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES
Party NameBRILL PHARMA, S.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events

Event DateEvent Description
Friday, September 28, 2018NON-FINAL ACTION WRITTEN
Thursday, September 27, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 28, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 28, 2018ASSIGNED TO EXAMINER
Saturday, September 29, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 2, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, October 9, 2018REFUSAL PROCESSED BY MPU
Tuesday, October 9, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 26, 2018REFUSAL PROCESSED BY IB
Monday, February 4, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 21, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 25, 2019ASSIGNED TO LIE
Wednesday, March 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 1, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, June 6, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 6, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, June 26, 2019ASSIGNED TO PETITION STAFF
Thursday, June 27, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Sunday, August 11, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, September 17, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, December 17, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, January 8, 2020FINAL DISPOSITION PROCESSED
Friday, January 24, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, January 8, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 11, 2020NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 30, 2020NEW REPRESENTATIVE AT IB RECEIVED
Sunday, November 1, 2020CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, December 17, 2020CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, April 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, April 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, April 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 17, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Related Keywords

ectodol products pharmaceutical diseases pharmaceuticals liver thyroid hyperproliferative excluding foregoing treating